Solifenacin for Urgency Urinary Incontinence
Start solifenacin at 5 mg once daily, and increase to 10 mg once daily if symptoms persist after initial trial and the 5 mg dose is well tolerated. 1
Dosing Recommendations
Standard Dosing
- Initial dose: 5 mg orally once daily
- Titration: May increase to 10 mg once daily if 5 mg is well tolerated
- Take with water, swallow whole; can be administered with or without food 1
Dose Adjustments Required
Do NOT exceed 5 mg once daily in the following situations:
- Severe renal impairment (creatinine clearance <30 mL/min/1.73 m²) 1
- Moderate hepatic impairment (Child-Pugh B) 1
- Concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole) 1, 2
Do NOT use in:
- Severe hepatic impairment (Child-Pugh C) 1
Contraindications
Solifenacin is absolutely contraindicated in patients with: 1
- Urinary retention
- Gastric retention
- Uncontrolled narrow-angle glaucoma
- Hypersensitivity to solifenacin (including prior anaphylaxis or angioedema)
Critical Warnings and Precautions
Use with Extreme Caution In:
The 2024 AUA/SUFU guidelines emphasize that antimuscarinics like solifenacin should be used with extreme caution in patients with: 3
- Narrow-angle glaucoma (even if controlled)
- Impaired gastric emptying
- History of urinary retention
- Diabetes, prior abdominal surgery, narcotic use, scleroderma, hypothyroidism, Parkinson's disease, multiple sclerosis
Dementia Risk - Critical Counseling Point
You must discuss the potential risk for developing dementia and cognitive impairment with all patients prescribed solifenacin. 3 Evidence suggests an association between antimuscarinic medications and incident dementia that may be cumulative and dose-dependent. The 2024 guidelines recommend preferentially trialing beta-3 agonists (like mirabegron) before antimuscarinics when possible. 3
Life-Threatening Reactions
- Angioedema and anaphylaxis: Can occur after first dose or after multiple doses. If tongue, hypopharynx, or larynx involvement occurs, immediately discontinue solifenacin and secure airway 1
- QT prolongation: Not recommended in patients at high risk of QT prolongation or taking QT-prolonging medications 1
Monitoring
Clinical Monitoring
- Post-void residual (PVR): Monitor for urinary retention, especially in patients at risk (those with bladder outlet obstruction, prior retention history) 3
- Symptom response: Assess improvement in urgency, frequency, and incontinence episodes. Full therapeutic effects occur after 2-4 weeks of treatment 2
- Cognitive function: Particularly in elderly patients given dementia risk 3
- Adverse effects: Dry mouth, constipation (most common), blurred vision, urinary tract infections 1
When to Reassess
If no improvement is noted after adequate trial, discontinue and pursue other treatments. The guidelines support combining therapies (behavioral therapy, beta-3 agonists) if monotherapy fails, but add therapies stepwise to determine individual impact. 3
Efficacy Evidence
Solifenacin significantly improves all major OAB symptoms: 3, 4, 5
- Reduces urgency episodes, incontinence episodes, micturition frequency, and nocturia
- Increases volume voided per micturition
- Approximately 50% of incontinent patients achieve continence after 12 weeks 4, 6
Combination Therapy
If monotherapy fails, consider combining solifenacin 5 mg with mirabegron 50 mg - this combination showed superior efficacy to either monotherapy in the SYNERGY trials, with additive effects on urgency, incontinence, and nocturia. 7 However, adverse events (dry mouth, constipation, urinary retention indicators) increase with combination therapy. 7
Common Pitfalls to Avoid
- Failing to counsel on dementia risk - This is now a clinical principle in the 2024 guidelines 3
- Not checking for contraindications - Particularly urinary retention risk and narrow-angle glaucoma 1
- Exceeding 5 mg in patients on CYP3A4 inhibitors - Drug interactions significantly increase solifenacin exposure 1, 2
- Not monitoring for urinary retention - Especially critical in elderly men with possible prostatic obstruction 3
- Expecting immediate results - Counsel patients that full effects take 2-4 weeks 2